The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population

Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism of the IL-8 promoter is involved in s...

Full description

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 11; no. 18; pp. 6431 - 6441
Main Authors LEE, Wei-Ping, TAI, Dar-In, CHAO, Yee, YEN, Shang-Heu, LEE, Shou-Dong, LAN, Keng-Hsin, LI, Anna Fen-Yau, HSU, Hou-Ching, LIN, En-Ju, LIN, Yi-Ping, SHEU, Meei-Ling, LI, Chung-Pin, CHANG, Full-Young
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 15.09.2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the −251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the −251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. Experimental Design: The −251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the −251A/T promoters was analyzed by electrophoretic mobility shift assay. The −251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the −251A/T promoters was done by a case-control study. Results: The −251T allele possessed transcriptional activity 2- to 5-fold stronger than the −251A counterpart. Electrophoretic mobility shift assay showed that the −251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The −251T allele was associated with increased risk of noncardia ( P trend = 0.012) and cardia ( P trend = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (χ 2 = 6.816; P = 0.033); however, the high-risk −251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. Conclusions: The IL-8 −251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population.
AbstractList PURPOSE: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1 beta polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The -251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the -251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the -251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. Experimental Design: The -251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the -251A/T promoters was analyzed by electrophoretic mobility shift assay. The -251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the -251A/T promoters was done by a case-control study. RESULTS: The -251T allele possessed transcriptional activity 2- to 5-fold stronger than the -251A counterpart. Electrophoretic mobility shift assay showed that the -251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The -251T allele was associated with increased risk of noncardia (P sub(trend) = 0.012) and cardia (P sub(trend) = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas ( chi super(2) = 6.816; P = 0.033); however, the high-risk -251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. CONCLUSIONS: The IL-8 -251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population.
Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The -251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the -251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the -251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. The -251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the -251A/T promoters was analyzed by electrophoretic mobility shift assay. The -251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the -251A/T promoters was done by a case-control study. The -251T allele possessed transcriptional activity 2- to 5-fold stronger than the -251A counterpart. Electrophoretic mobility shift assay showed that the -251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The -251T allele was associated with increased risk of noncardia (P(trend) = 0.012) and cardia (P(trend) = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (chi(2) = 6.816; P = 0.033); however, the high-risk -251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. The IL-8 -251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population.
Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the −251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the −251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. Experimental Design: The −251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the −251A/T promoters was analyzed by electrophoretic mobility shift assay. The −251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the −251A/T promoters was done by a case-control study. Results: The −251T allele possessed transcriptional activity 2- to 5-fold stronger than the −251A counterpart. Electrophoretic mobility shift assay showed that the −251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The −251T allele was associated with increased risk of noncardia ( P trend = 0.012) and cardia ( P trend = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (χ 2 = 6.816; P = 0.033); however, the high-risk −251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. Conclusions: The IL-8 −251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population.
Abstract Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The −251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the −251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the −251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma. Experimental Design: The −251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the −251A/T promoters was analyzed by electrophoretic mobility shift assay. The −251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the −251A/T promoters was done by a case-control study. Results: The −251T allele possessed transcriptional activity 2- to 5-fold stronger than the −251A counterpart. Electrophoretic mobility shift assay showed that the −251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The −251T allele was associated with increased risk of noncardia (Ptrend = 0.012) and cardia (Ptrend = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (χ2 = 6.816; P = 0.033); however, the high-risk −251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas. Conclusions: The IL-8 −251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population.
PURPOSEPersistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance the cytokine production, are associated with increased risk of gastric cancer. The -251A/T polymorphism of the IL-8 promoter is involved in several human diseases. Particularly, the -251A is associated with decreased risk of colorectal cancer. We aimed to determine whether the -251 allele resulting in high IL-8 expression was associated with increased risk of gastric carcinoma.EXPERIMENTAL DESIGNThe -251A/T promoters were cloned and analyzed by luciferase assay. Binding of nuclear proteins to the -251A/T promoters was analyzed by electrophoretic mobility shift assay. The -251A/T promoters were differentiated by PCR-RFLP. Comparison of gastric cancer risk between the -251A/T promoters was done by a case-control study.RESULTSThe -251T allele possessed transcriptional activity 2- to 5-fold stronger than the -251A counterpart. Electrophoretic mobility shift assay showed that the -251A promoter had strong ability to bind to an unknown protein or multiprotein complex. The -251T allele was associated with increased risk of noncardia (P(trend) = 0.012) and cardia (P(trend) = 0.029) carcinomas. Gastric carcinoma patients with the low-risk AA genotype had a tendency to sustain intestinal-type carcinomas (chi(2) = 6.816; P = 0.033); however, the high-risk -251T allele was associated with >2-fold increased risk of diffuse-type (AA versus AT + TT: odds ratio, 2.52; 95% confidence interval, 1.16-5.49; P = 0.017) and mixed-type (AA versus AT + TT: odds ratio, 2.22; 95% confidence interval, 1.12-4.40; P = 0.019) carcinomas.CONCLUSIONSThe IL-8 -251T allele is significantly associated with increased risk of gastric carcinoma, particularly the diffuse and mixed types in Chinese population.
Author Yee Chao
Anna Fen-Yau Li
Chung-Pin Li
Meei-Ling Sheu
Yi-Ping Lin
Shang-Heu Yen
Dar-In Tai
Wei-Ping Lee
En-Ju Lin
Full-Young Chang
Hou-Ching Hsu
Shou-Dong Lee
Keng-Hsin Lan
Author_xml – sequence: 1
  givenname: Wei-Ping
  surname: LEE
  fullname: LEE, Wei-Ping
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 2
  givenname: Dar-In
  surname: TAI
  fullname: TAI, Dar-In
  organization: The Liver Research Unit, Department of Gastroenterolooy and Hcpatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
– sequence: 3
  givenname: Yee
  surname: CHAO
  fullname: CHAO, Yee
  organization: School of Mediciine, National Yang Ming University, Taiwan, Province of China
– sequence: 4
  givenname: Shang-Heu
  surname: YEN
  fullname: YEN, Shang-Heu
  organization: School of Mediciine, National Yang Ming University, Taiwan, Province of China
– sequence: 5
  givenname: Shou-Dong
  surname: LEE
  fullname: LEE, Shou-Dong
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 6
  givenname: Keng-Hsin
  surname: LAN
  fullname: LAN, Keng-Hsin
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 7
  givenname: Anna Fen-Yau
  surname: LI
  fullname: LI, Anna Fen-Yau
  organization: Department of Pathology, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 8
  givenname: Hou-Ching
  surname: HSU
  fullname: HSU, Hou-Ching
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 9
  givenname: En-Ju
  surname: LIN
  fullname: LIN, En-Ju
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 10
  givenname: Yi-Ping
  surname: LIN
  fullname: LIN, Yi-Ping
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 11
  givenname: Meei-Ling
  surname: SHEU
  fullname: SHEU, Meei-Ling
  organization: Department of Toxicology, National Taiwan University College of Medicine, Taipei, Taiwan, Province of China
– sequence: 12
  givenname: Chung-Pin
  surname: LI
  fullname: LI, Chung-Pin
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
– sequence: 13
  givenname: Full-Young
  surname: CHANG
  fullname: CHANG, Full-Young
  organization: Division of Gastroenterology, Department of Meilicine, Taipei Veterans General Hospital, Taiwan, Province of China
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17118274$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16166417$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFuFCEYx4mpse3qI2i4aOJhKswAwx43o203aWLTrGfCsN_sYGdhBCbNvoFnX8E380lksmt69AR8-f2B_H-X6Mx5Bwi9peSKUi4_UVLLgrCqvGqah4LwgixZ-QJdUM7roioFP8v7f8w5uozxOyGUUcJeoXMqqBCM1hfo96YH_Ofnr5LTDV4NAwyAfYdTnq5dgjDA9GhdIfF98HufB3gd8SpGb6xOsMVPNvWZNAF0zMcHGx_n_I2OKViDGx2MdX6v8TXoNAXrdviz7bopQrE5jIBvbUx-1Kn3g98dsHW46a2DCPjej9Ogk_XuNXrZ6SHCm9O6QN-uv2ya2-Lu6826Wd0VhpEyFZ2RLalZJUzFRc1M29ZGLEuzZKztjJGlbPUWOkbokjJDclHSsGpLasO5qISsFujD8d4x-B8TxKT2NhoYBu3AT1EJyaVktPovSOvcLV2SDPIjaIKPMUCnxmD3OhwUJWrWqGZFalakskZFuJo15ty70wNTu4ftc-rkLQPvT4CORg9d0M7Y-MzVlMoyd7FAH49cb3f9kw2gTCYhhNxwVtPnTygqlWAVrf4CThq3Sg
CitedBy_id crossref_primary_10_2217_17410541_5_6_589
crossref_primary_10_1111_j_1751_2980_2009_00380_x
crossref_primary_10_1016_j_dld_2008_02_031
crossref_primary_10_1016_j_humimm_2006_03_018
crossref_primary_10_1042_BJ20071341
crossref_primary_10_1093_annonc_mdn368
crossref_primary_10_1093_annonc_mdn400
crossref_primary_10_1093_aje_kwq370
crossref_primary_10_1586_17474124_2_4_577
crossref_primary_10_1155_2018_3148137
crossref_primary_10_1016_j_taap_2013_05_019
crossref_primary_10_1177_1010428317705747
crossref_primary_10_3748_wjg_14_5744
crossref_primary_10_1038_nrc2069
crossref_primary_10_1016_j_psychres_2020_113421
crossref_primary_10_1002_path_5214
crossref_primary_10_1189_jlb_4BT0214_100R
crossref_primary_10_1371_journal_pone_0104436
crossref_primary_10_3109_03009742_2012_726372
crossref_primary_10_1016_j_humimm_2007_06_006
crossref_primary_10_1111_j_1744_313X_2012_01096_x
crossref_primary_10_1016_j_cyto_2022_155806
crossref_primary_10_1016_j_cyto_2012_06_239
crossref_primary_10_1111_j_1365_2249_2007_03489_x
crossref_primary_10_1111_j_1365_2591_2012_02097_x
crossref_primary_10_1089_dna_2011_1438
crossref_primary_10_1007_s11060_015_2005_9
crossref_primary_10_1097_IAE_0b013e318285cf92
crossref_primary_10_1186_1471_2407_8_326
crossref_primary_10_3892_mco_2016_1044
crossref_primary_10_1111_j_1440_1746_2008_05314_x
crossref_primary_10_1016_j_humimm_2013_06_033
crossref_primary_10_1371_journal_pone_0090945
crossref_primary_10_1007_s00408_017_0058_6
crossref_primary_10_1007_s11033_011_1042_5
crossref_primary_10_1186_s43042_022_00348_z
crossref_primary_10_1017_S0950268809990677
crossref_primary_10_1016_j_bpg_2007_02_002
crossref_primary_10_2217_fon_10_13
crossref_primary_10_1111_j_1469_0691_2009_03031_x
crossref_primary_10_1016_j_cyto_2017_06_001
crossref_primary_10_1111_j_1440_1746_2009_06188_x
crossref_primary_10_1007_s11596_011_0161_5
crossref_primary_10_1111_hel_12297
crossref_primary_10_3390_ijms19103214
crossref_primary_10_1111_j_1440_1827_2010_02567_x
crossref_primary_10_1097_MCG_0b013e318178d1d3
crossref_primary_10_1016_j_yexmp_2017_07_004
crossref_primary_10_1186_1465_9921_12_73
crossref_primary_10_25048_tudod_1198053
crossref_primary_10_1007_s13277_015_3593_x
crossref_primary_10_1016_j_ejca_2010_03_011
crossref_primary_10_1038_onc_2010_352
crossref_primary_10_1016_j_cyto_2021_155489
crossref_primary_10_3945_jn_108_101865
crossref_primary_10_1080_21655979_2021_1933680
crossref_primary_10_1016_j_genrep_2022_101500
crossref_primary_10_1177_145749690609500402
crossref_primary_10_1186_s41043_021_00280_9
crossref_primary_10_1016_j_clim_2007_07_010
crossref_primary_10_1007_s10620_009_0978_y
crossref_primary_10_3390_biomedicines12020321
crossref_primary_10_1517_14728222_2012_677440
crossref_primary_10_1111_j_1440_1746_2010_06310_x
crossref_primary_10_1111_j_1601_0825_2011_01882_x
crossref_primary_10_1016_j_meegid_2011_02_014
crossref_primary_10_1007_s13277_014_1881_5
crossref_primary_10_1016_j_intimp_2019_106026
crossref_primary_10_1002_mc_20661
crossref_primary_10_1016_j_jcmgh_2017_03_005
crossref_primary_10_1186_1471_2407_7_70
crossref_primary_10_1016_j_jcmgh_2022_01_022
crossref_primary_10_1089_jir_2009_0007
crossref_primary_10_1016_j_cyto_2017_07_006
crossref_primary_10_1016_j_mrfmmm_2008_06_006
crossref_primary_10_7314_APJCP_2014_15_7_2951
crossref_primary_10_1111_j_1365_2036_2007_03268_x
crossref_primary_10_1016_j_ophtha_2010_10_014
crossref_primary_10_29058_mjwbs_1339421
crossref_primary_10_1089_dna_2012_1692
crossref_primary_10_1038_bjc_2012_177
crossref_primary_10_1099_jmm_0_058073_0
crossref_primary_10_1016_j_amjms_2021_01_017
crossref_primary_10_1371_journal_pone_0028083
crossref_primary_10_1097_CEJ_0b013e32809b4d0f
crossref_primary_10_1007_s10753_009_9160_0
crossref_primary_10_1007_s11033_013_2993_5
crossref_primary_10_1111_acps_12339
crossref_primary_10_7314_APJCP_2013_14_7_4403
crossref_primary_10_1016_j_bpg_2006_04_006
crossref_primary_10_1016_j_cyto_2013_11_001
crossref_primary_10_1007_s10552_007_0129_8
crossref_primary_10_1172_JCI30111
crossref_primary_10_1186_s12885_017_3378_2
crossref_primary_10_3109_08916934_2015_1134507
crossref_primary_10_1007_s10528_015_9704_y
crossref_primary_10_1016_j_bbcan_2010_01_007
crossref_primary_10_1016_j_hoc_2010_06_007
crossref_primary_10_1053_j_gastro_2007_11_009
crossref_primary_10_7704_kjhugr_2016_16_2_73
crossref_primary_10_1016_j_canlet_2010_04_025
crossref_primary_10_1016_j_ctrv_2013_02_004
crossref_primary_10_1111_j_1523_5378_2007_00575_x
crossref_primary_10_1097_MCG_0b013e3181646701
crossref_primary_10_1002_ijc_21979
crossref_primary_10_1016_j_cca_2006_08_023
crossref_primary_10_1155_2009_212345
crossref_primary_10_1002_jso_22037
crossref_primary_10_1111_tmi_12787
crossref_primary_10_1093_annonc_mdp280
crossref_primary_10_1111_cei_12592
crossref_primary_10_1016_j_ejca_2009_03_017
Cites_doi 10.4049/jimmunol.170.6.3369
10.1111/j.1365-2249.2003.02305.x
10.1053/gast.1996.v110.pm8964399
10.1074/jbc.M305536200
10.1056/NEJMoa001999
10.1053/gast.2002.37043
10.1111/j.1365-2362.1992.tb01480.x
10.1172/JCI114265
10.1056/NEJM199110173251603
10.1016/S0959-8049(01)00147-2
10.3109/07853899809002488
10.1078/0344-0338-00038
10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K
10.1056/NEJMra020542
10.1053/gast.2001.28000
10.1042/bj3480473
10.1136/jcp.47.4.318
10.1016/j.humimm.2004.01.015
10.1016/j.jaci.2004.06.038
10.1126/science.1281554
10.1053/gast.2002.34781
10.1016/1043-4666(89)91043-0
10.1111/apm.1965.64.1.31
10.1016/S0016-5085(03)00899-0
10.1111/j.1365-2249.1995.tb05549.x
10.1097/00002030-200405210-00016
10.1046/j.1523-5378.2003.00130.x
10.1046/j.1365-3083.1998.00300.x
10.1007/BF03257159
10.1016/S0016-5085(03)00157-4
10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4
10.1038/sj.gene.6364067
10.1038/35006081
10.1016/S0954-6111(98)90118-4
10.1038/sj.bjc.6690742
10.4049/jimmunol.160.5.2401
10.1074/jbc.M207418200
10.1136/thorax.55.12.1023
10.1111/j.1365-2559.1987.tb01863.x
10.1002/ijc.11724
ContentType Journal Article
Copyright 2005 INIST-CNRS
Copyright_xml – notice: 2005 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TO
H94
7X8
DOI 10.1158/1078-0432.CCR-05-0942
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList Oncogenes and Growth Factors Abstracts
MEDLINE

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1557-3265
EndPage 6441
ExternalDocumentID 10_1158_1078_0432_CCR_05_0942
16166417
17118274
11_18_6431
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GeographicLocations Asia
China
GeographicLocations_xml – name: China
GroupedDBID -
08R
29B
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
AAPBV
ABFLS
ABOCM
ACIWK
ACPRK
ADACO
ADBBV
ADBIT
AENEX
AETEA
AFFNX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
GJ
GX1
H13
H~9
IH2
KQ8
L7B
LSO
MVM
O0-
OHT
OK1
P0W
P2P
RCR
RHF
RHI
RNS
SJN
UDS
VH1
W2D
WOQ
X7M
XFK
XJT
ZA5
ZCG
ZGI
---
.55
.GJ
18M
1CY
2FS
476
4H-
6J9
AAUGY
ACGFO
ACSVP
ADCOW
ADNWM
AFHIN
AFOSN
AI.
BR6
BTFSW
IQODW
J5H
QTD
TR2
W8F
WHG
YKV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TO
H94
7X8
ID FETCH-LOGICAL-c402t-fc8b07436c35674cbb7c692c944bfcc828badef401914c01558c43d07c5563683
ISSN 1078-0432
IngestDate Sun Sep 29 07:16:07 EDT 2024
Sun Sep 29 08:40:35 EDT 2024
Thu Sep 26 15:52:03 EDT 2024
Sat Sep 28 07:51:08 EDT 2024
Sun Oct 29 17:07:56 EDT 2023
Fri Jan 15 20:06:56 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 18
Keywords Human
Angiogenic factor
Transcription promoter
Cytokine
Risk
Malignant tumor
Epidemiology
Stomach carcinoma
Allele
Anatomic pathology
Histopathology
Risk factor
Digestive diseases
Chinese
Genetics
Interleukin 8
Gastric disease
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c402t-fc8b07436c35674cbb7c692c944bfcc828badef401914c01558c43d07c5563683
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16166417
PQID 17417190
PQPubID 23462
PageCount 11
ParticipantIDs proquest_miscellaneous_68588413
proquest_miscellaneous_17417190
crossref_primary_10_1158_1078_0432_CCR_05_0942
pubmed_primary_16166417
pascalfrancis_primary_17118274
highwire_cancerresearch_11_18_6431
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 2005-09-15
PublicationDateYYYYMMDD 2005-09-15
PublicationDate_xml – month: 09
  year: 2005
  text: 2005-09-15
  day: 15
PublicationDecade 2000
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
PublicationTitle Clinical cancer research
PublicationTitleAlternate Clin Cancer Res
PublicationYear 2005
Publisher American Association for Cancer Research
Publisher_xml – name: American Association for Cancer Research
References 2022061104165998600_B39
2022061104165998600_B38
2022061104165998600_B37
2022061104165998600_B36
2022061104165998600_B35
2022061104165998600_B34
2022061104165998600_B33
2022061104165998600_B32
2022061104165998600_B31
2022061104165998600_B30
2022061104165998600_B49
2022061104165998600_B48
2022061104165998600_B47
2022061104165998600_B46
2022061104165998600_B45
2022061104165998600_B44
2022061104165998600_B43
2022061104165998600_B42
2022061104165998600_B41
2022061104165998600_B40
2022061104165998600_B19
2022061104165998600_B18
2022061104165998600_B17
2022061104165998600_B16
2022061104165998600_B15
2022061104165998600_B14
2022061104165998600_B13
2022061104165998600_B12
2022061104165998600_B11
2022061104165998600_B10
2022061104165998600_B6
2022061104165998600_B5
2022061104165998600_B8
2022061104165998600_B7
2022061104165998600_B2
2022061104165998600_B1
2022061104165998600_B4
2022061104165998600_B3
2022061104165998600_B29
2022061104165998600_B28
2022061104165998600_B27
2022061104165998600_B26
2022061104165998600_B25
2022061104165998600_B24
2022061104165998600_B23
2022061104165998600_B22
2022061104165998600_B21
2022061104165998600_B20
2022061104165998600_B9
References_xml – ident: 2022061104165998600_B16
  doi: 10.4049/jimmunol.170.6.3369
– ident: 2022061104165998600_B26
  doi: 10.1111/j.1365-2249.2003.02305.x
– ident: 2022061104165998600_B4
  doi: 10.1053/gast.1996.v110.pm8964399
– ident: 2022061104165998600_B34
  doi: 10.1074/jbc.M305536200
– ident: 2022061104165998600_B2
  doi: 10.1056/NEJMoa001999
– ident: 2022061104165998600_B5
  doi: 10.1053/gast.2002.37043
– ident: 2022061104165998600_B43
  doi: 10.1111/j.1365-2362.1992.tb01480.x
– ident: 2022061104165998600_B36
– ident: 2022061104165998600_B11
  doi: 10.1172/JCI114265
– ident: 2022061104165998600_B1
  doi: 10.1056/NEJM199110173251603
– ident: 2022061104165998600_B22
  doi: 10.1016/S0959-8049(01)00147-2
– ident: 2022061104165998600_B46
  doi: 10.3109/07853899809002488
– ident: 2022061104165998600_B42
  doi: 10.1078/0344-0338-00038
– ident: 2022061104165998600_B48
– ident: 2022061104165998600_B44
  doi: 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K
– ident: 2022061104165998600_B3
  doi: 10.1056/NEJMra020542
– ident: 2022061104165998600_B7
  doi: 10.1053/gast.2001.28000
– ident: 2022061104165998600_B35
  doi: 10.1042/bj3480473
– ident: 2022061104165998600_B18
– ident: 2022061104165998600_B24
– ident: 2022061104165998600_B37
  doi: 10.1136/jcp.47.4.318
– ident: 2022061104165998600_B32
  doi: 10.1016/j.humimm.2004.01.015
– ident: 2022061104165998600_B28
  doi: 10.1016/j.jaci.2004.06.038
– ident: 2022061104165998600_B17
  doi: 10.1126/science.1281554
– ident: 2022061104165998600_B12
  doi: 10.1053/gast.2002.34781
– ident: 2022061104165998600_B10
  doi: 10.1016/1043-4666(89)91043-0
– ident: 2022061104165998600_B41
  doi: 10.1111/apm.1965.64.1.31
– ident: 2022061104165998600_B8
  doi: 10.1016/S0016-5085(03)00899-0
– ident: 2022061104165998600_B15
– ident: 2022061104165998600_B47
  doi: 10.1111/j.1365-2249.1995.tb05549.x
– ident: 2022061104165998600_B31
  doi: 10.1097/00002030-200405210-00016
– ident: 2022061104165998600_B33
  doi: 10.1046/j.1523-5378.2003.00130.x
– ident: 2022061104165998600_B45
  doi: 10.1046/j.1365-3083.1998.00300.x
– ident: 2022061104165998600_B38
– ident: 2022061104165998600_B49
  doi: 10.1007/BF03257159
– ident: 2022061104165998600_B9
  doi: 10.1016/S0016-5085(03)00157-4
– ident: 2022061104165998600_B20
  doi: 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4
– ident: 2022061104165998600_B30
  doi: 10.1038/sj.gene.6364067
– ident: 2022061104165998600_B6
  doi: 10.1038/35006081
– ident: 2022061104165998600_B19
– ident: 2022061104165998600_B25
– ident: 2022061104165998600_B21
  doi: 10.1016/S0954-6111(98)90118-4
– ident: 2022061104165998600_B27
  doi: 10.1038/sj.bjc.6690742
– ident: 2022061104165998600_B13
  doi: 10.4049/jimmunol.160.5.2401
– ident: 2022061104165998600_B40
  doi: 10.1074/jbc.M207418200
– ident: 2022061104165998600_B14
– ident: 2022061104165998600_B29
  doi: 10.1136/thorax.55.12.1023
– ident: 2022061104165998600_B39
  doi: 10.1111/j.1365-2559.1987.tb01863.x
– ident: 2022061104165998600_B23
  doi: 10.1002/ijc.11724
SSID ssj0014104
Score 2.271575
Snippet Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which enhance...
Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance the...
Abstract Purpose: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1β polymorphisms, which...
PURPOSE: Persistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1 beta polymorphisms, which...
PURPOSEPersistent interleukin-8 (IL-8) production contributes to chronic inflammation of the stomach. The proinflammatory IL-1beta polymorphisms, which enhance...
SourceID proquest
crossref
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 6431
SubjectTerms Adult
Aged
Alleles
Antineoplastic agents
Base Sequence
Biological and medical sciences
Case-Control Studies
Cell Line, Tumor
Chi-Square Distribution
China
Female
gastric cancer
Gastroenterology. Liver. Pancreas. Abdomen
Gene Frequency
Genotype
Helicobacter Infections - genetics
Helicobacter Infections - microbiology
Helicobacter pylori
Humans
Interleukin-8
Interleukin-8 - genetics
Male
Medical sciences
Middle Aged
Odds Ratio
Pharmacology. Drug treatments
polymorphism
Polymorphism, Single Nucleotide
Promoter Regions, Genetic - genetics
Risk Factors
Stomach Neoplasms - genetics
Stomach Neoplasms - microbiology
Stomach Neoplasms - pathology
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tumor Cells, Cultured
Tumors
Title The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population
URI http://clincancerres.aacrjournals.org/content/11/18/6431.abstract
https://www.ncbi.nlm.nih.gov/pubmed/16166417
https://search.proquest.com/docview/17417190
https://search.proquest.com/docview/68588413
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiPeWx2IhbpVLHk7iHFG1S0G7C0KtKCcrdp0lYklXTXPh18A_ZSbOU-qKxyWqonh6-L6Mx5NvZgh5pVUgonWSMM9zOeM6TpkS3GWKizUQShnHweLks_NwvuTvV8FqNPrZUy2VOzXVP_bWlfwPqnAPcMUq2X9AtjUKN-A34AtXQBiuf40xg9BhMcGJKJftB3_sAbG9NOW3LGcCJViAh9ni7PKkRqMRnWc5Ro2F6TTmFwlO8tDYslpn-eZ7MkkNNv_ElAJOUykLw6q8bdWpGAca2y5OWD34tZpnOblqh4L1Q99ZU4OpkWjbSd1mqE1H15KgzyZjH5v9tEop1KXwW_aukw_ZtC3sEhdsXmTd_cyKNPNkAkCxL0k5yGoEKMGwdZ21I3aw8y_3h57a7TNS9PwuxFVubw_HIG___hCIKlVRG5_OZp8q9WJsW3wN-3Gff5Any9NTuTheLW6Qmx64MvShb1etiAhFstyqWq3BukYM_ub13j8ZRj9NR2oU5CYFIJDaYSrXn3aqqGdxl9ypjyv0jeXePTIy-X1y66wWZDwgv4CCtKIgtRSkm5QCBemAgrShIM0K2lGQIgVpS0GKFMT1NQVpS0HaUpD2KUiHFARLtKYg7Sj4kCxPjhezOaunfjDNHW_HUi0UxrWh9oMw4lqpSIexp2POVaq18IRK1iblDnYm1BjyC839tRNp7HUXCv8ROcg3uTkkFIJTDTZ8N1AuX3tJHJhQOIrH3E_iMDBjMm3QkFe2uYusDsWBkAifRPgkwCedQCJ8Y_KywUzal6V5V2CRdIVEHo7J0QDNznSEp_mIj8mLBl4Jzhy_0CW52ZQFPMHhodi5_gkcFwG-1B-Tx5YXnfXQDUNY_uSPa5-S290r94wc7LaleQ6h9U4dVez-DZrB0MY
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+-251T+allele+of+the+interleukin-8+promoter+is+associated+with+increased+risk+of+gastric+carcinoma+featuring+diffuse-type+histopathology+in+Chinese+population&rft.jtitle=Clinical+cancer+research&rft.au=Lee%2C+Wei-Ping&rft.au=Tai%2C+Dar-In&rft.au=Lan%2C+Keng-Hsin&rft.au=Li%2C+Anna+Fen-Yau&rft.date=2005-09-15&rft.issn=1078-0432&rft.volume=11&rft.issue=18&rft.spage=6431&rft.epage=6441&rft_id=info:doi/10.1158%2F1078-0432.CCR-05-0942&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0432&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0432&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0432&client=summon